PDF(1861 KB)
Chinese expert consensus on comprehensive pharmaceutical management of cardiovascular toxicity of tyrosine kinase inhibitors
Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association, The Cardio-Oncology Group of the Chinese Society of Cardiovascular Diseases of Chinese Medical Association, Writing Group of Chinese Expert Consensus on Pharmaceutical Management of Cardiovascular Toxicity of Tyrosine Kinase Inhibitors
Chinese Journal of Hospital Pharmacy ›› 2023, Vol. 43 ›› Issue (19) : 2119-2135.
PDF(1861 KB)
PDF(1861 KB)
Chinese expert consensus on comprehensive pharmaceutical management of cardiovascular toxicity of tyrosine kinase inhibitors
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
